Medical University of Vienna, Department of Medicine III, ICU
Vienna, 1090, Austria
NCT Number: NCT00590928
H2-receptor antagonists are the gold standard for stress ulcer prophylaxis in critically ill patients. Various studies demonstrated superiority of proton pump inhibitors over H2-receptor antagonists in increasing gastric pH and in healing gastric acid-dependent diseases. It is unknown, whether proton pump inhibitors are more effective in increasing gastric pH than H2-receptor antagonists in critically ill patients requiring stress ulcer prophylaxis.
Looking for future studies?
Notify Me18 year–80 year
All sexes
Interventional
Phase 4
Vienna, 1090, Austria
Gastric pH is measured continuously for 72 hours with a pipolar microelectrode placed between 7 and 15cm below the lower esophageal sphincter.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
40mg once daily
50mg every h hours
Time frame: 72 hours
Time frame: 72 hours
Time frame: 72 hours
Time frame: ICU stay
Time frame: 72 hours
Medical University of Vienna
Other
Effect of Intravenous Esomeprazole Versus Ranitidine on Gastric pH in Critically Ill Patients - a Prospective, Randomized, Double-Blind Study.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05464979
Critically Ill Patients
Wuhan, Hubei, China
View Trial DetailsNCT07025941
Acute Kidney Injury, Acute Kidney Injury (AKI)
Taizhou, Jiangsu, China
View Trial DetailsNCT06580704
Anesthesia, Critically Ill Patients
Tanta, El-Gharbia, Egypt
View Trial DetailsNCT05790915
Critically Ill Patients
São Luís, Maranhão, Brazil
View Trial Details